Comparison of the Efficacy of Two Novel Antitubercular Agents in Free and Liposome-Encapsulated Formulations

Tuberculosis is one of the top ten causes of death worldwide, and due to the appearance of drug-resistant strains, the development of new antituberculotic agents is a pressing challenge. Employing an in silico docking method, two coumaran (2,3-dihydrobenzofuran) derivatives—TB501 and TB515—were dete...

Descripción completa

Detalles Bibliográficos
Autores principales: Kósa, Nikoletta, Zolcsák, Ádám, Voszka, István, Csík, Gabriella, Horváti, Kata, Horváth, Lilla, Bősze, Szilvia, Herenyi, Levente
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7957691/
https://www.ncbi.nlm.nih.gov/pubmed/33671100
http://dx.doi.org/10.3390/ijms22052457

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7957691/
https://www.ncbi.nlm.nih.gov/pubmed/33671100
http://dx.doi.org/10.3390/ijms22052457

Ejemplares similares